US Patent 7524935 Sequences characteristic of hypoxia-regulated gene transcription
Patent 7524935 was granted and assigned to Quark Pharmaceuticals Inc on April, 2009 by the United States Patent and Trademark Office.
All edits
There are provided polynucleotides that are modulated by hypoxic conditions. The disclosure includes such genes and proteins as well as analogs, salts and functional derivatives of such proteins, and DNA encoding such analogs, and methods of use. Methods for treating the effects of stroke, hypoxia and/or ischemia by regulating such genes or proteins are also disclosed. The presence of hypoxia or a hypoxia-associated pathology may be diagnosed by screening for the presence of at least one polynucleotide having the nucleic acid sequence according to the present invention. Methods of regulating hypoxia associated pathologies are also provided.
US Patent 07524935 Sequences characteristic of hypoxia-regulated gene transcription US Patent 7524935 Sequences characteristic of hypoxia-regulated gene transcription
US Patent 07524935 Sequences characteristic of hypoxia-regulated gene transcription
Find more entities like US Patent 7524935 Sequences characteristic of hypoxia-regulated gene transcription
